PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 182 filers reported holding PTC THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $155,401,002 | -44.4% | 6,934,449 | +1.0% | 0.00% | -50.0% |
| Q2 2023 | $279,254,168 | -8.1% | 6,866,343 | +9.5% | 0.01% | -11.1% |
| Q1 2023 | $303,718,313 | +20.8% | 6,269,990 | -4.8% | 0.01% | +12.5% |
| Q4 2022 | $251,370,901 | -18.0% | 6,585,562 | +7.8% | 0.01% | -20.0% |
| Q3 2022 | $306,641,000 | +28.2% | 6,108,417 | +2.3% | 0.01% | +25.0% |
| Q2 2022 | $239,263,000 | +2.7% | 5,972,622 | -4.4% | 0.01% | +33.3% |
| Q1 2022 | $233,018,000 | -8.4% | 6,245,417 | -2.3% | 0.01% | 0.0% |
| Q4 2021 | $254,511,000 | +5.2% | 6,389,941 | -1.7% | 0.01% | -14.3% |
| Q3 2021 | $241,965,000 | -12.2% | 6,502,733 | -0.3% | 0.01% | -12.5% |
| Q2 2021 | $275,573,000 | -6.3% | 6,519,367 | +5.0% | 0.01% | -11.1% |
| Q1 2021 | $294,053,000 | -20.1% | 6,210,207 | +3.0% | 0.01% | -25.0% |
| Q4 2020 | $367,897,000 | +37.0% | 6,028,119 | +5.0% | 0.01% | +20.0% |
| Q3 2020 | $268,459,000 | -6.7% | 5,742,425 | +1.3% | 0.01% | -9.1% |
| Q2 2020 | $287,628,000 | +25.7% | 5,668,695 | +10.5% | 0.01% | 0.0% |
| Q1 2020 | $228,755,000 | -3.1% | 5,127,914 | +4.3% | 0.01% | +22.2% |
| Q4 2019 | $236,047,000 | +48.3% | 4,914,593 | +4.4% | 0.01% | +28.6% |
| Q3 2019 | $159,160,000 | -21.4% | 4,706,096 | +4.5% | 0.01% | -22.2% |
| Q2 2019 | $202,619,000 | +31.0% | 4,502,671 | +9.6% | 0.01% | +28.6% |
| Q1 2019 | $154,621,000 | +21.5% | 4,107,898 | +10.8% | 0.01% | +16.7% |
| Q4 2018 | $127,233,000 | -25.6% | 3,707,241 | +1.9% | 0.01% | -14.3% |
| Q3 2018 | $171,067,000 | +46.9% | 3,639,709 | +5.4% | 0.01% | +40.0% |
| Q2 2018 | $116,441,000 | +31.1% | 3,452,161 | +5.2% | 0.01% | +25.0% |
| Q1 2018 | $88,804,000 | +72.1% | 3,281,710 | +6.1% | 0.00% | +100.0% |
| Q4 2017 | $51,599,000 | -17.9% | 3,093,399 | -1.6% | 0.00% | -33.3% |
| Q3 2017 | $62,887,000 | +9.4% | 3,142,776 | +0.2% | 0.00% | 0.0% |
| Q2 2017 | $57,482,000 | +79.2% | 3,135,944 | -3.8% | 0.00% | +50.0% |
| Q1 2017 | $32,080,000 | +5659.4% | 3,260,258 | +6291.0% | 0.00% | +100.0% |
| Q4 2016 | $557,000 | -31.7% | 51,013 | -12.4% | 0.00% | 0.0% |
| Q3 2016 | $816,000 | +101.0% | 58,239 | +0.7% | 0.00% | 0.0% |
| Q2 2016 | $406,000 | +28.9% | 57,806 | +18.4% | 0.00% | 0.0% |
| Q1 2016 | $315,000 | +854.5% | 48,825 | +4748.6% | 0.00% | – |
| Q4 2015 | $33,000 | -94.5% | 1,007 | -95.5% | 0.00% | -100.0% |
| Q3 2015 | $597,000 | -43.8% | 22,375 | +1.4% | 0.00% | -50.0% |
| Q2 2015 | $1,062,000 | +2555.0% | 22,063 | +3217.7% | 0.00% | – |
| Q1 2015 | $40,000 | +2.6% | 665 | -12.8% | 0.00% | – |
| Q4 2014 | $39,000 | +69.6% | 763 | +46.2% | 0.00% | – |
| Q3 2014 | $23,000 | +64.3% | 522 | 0.0% | 0.00% | – |
| Q2 2014 | $14,000 | +75.0% | 522 | +74.0% | 0.00% | – |
| Q1 2014 | $8,000 | +60.0% | 300 | 0.0% | 0.00% | – |
| Q4 2013 | $5,000 | +25.0% | 300 | +50.0% | 0.00% | – |
| Q3 2013 | $4,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ayer Capital Management, LP | 416,666 | $7,153,000 | 38.92% |
| Novo Holdings A/S | 747,359 | $11,210,000 | 2.78% |
| Bain Capital Public Equity Management, LLC | 2,333,333 | $50,073,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,027 | $18,134,000 | 0.84% |
| HealthCor Management, L.P. | 732,200 | $15,713,000 | 0.84% |
| RA Capital Management | 300,000 | $6,438,000 | 0.67% |
| Catalyst Capital Advisors LLC | 30,666 | $658,000 | 0.36% |
| CR Intrinsic Investors, LLC | 119,237 | $2,559,000 | 0.08% |
| Weiss Multi-Strategy Advisers LLC | 284,130 | $6,098,000 | 0.07% |
| SECTORAL ASSET MANAGEMENT INC | 57,519 | $1,234,000 | 0.06% |